Tibsovo 250 mg
Tibsovo 250 mg is a medicine authorised by Swissmedic under authorisation number 69077. The authorisation holder is Servier (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 June 2024 and the authorisation is limited until 12 June 2029. ATC code L01XM02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69077 |
|---|---|
| Name | Tibsovo 250 mg |
| Full name | Tibsovo 250 mg, comprimés pelliculés |
| Authorisation holder | Servier (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XM02 |
| First authorisation | 13 June 2024 |
| Authorisation validity | 12 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tibsovo 250 mg, comprimés pelliculés | A | 13 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01XM02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tibsovo 250 mg authorised in Switzerland?
Yes. Tibsovo 250 mg is authorised by Swissmedic under authorisation number 69077, data as of 01 September 2026. The authorisation is limited until 12 June 2029.
Which dispensing category does Tibsovo 250 mg have?
Tibsovo 250 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tibsovo 250 mg?
The authorisation holder is Servier (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.